November 16, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E., Mail Stop 3030
Washington, DC 20549
| Attn: | Dorrie Yale |
| Re: | Sonoma Pharmaceuticals, Inc. Registration Statement on Form S-1 Filed October 12, 2018, as amended File No. 333-227806 |
| Acceleration Request | |
Requested Date: November 16, 2018 Requested Time: 4:30 P.M. Eastern Standard Time | |
Dear Ms. Yale:
Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the “Company”), hereby requests that the above-captioned Registration Statement on Form S-1, as amended, (the “Registration Statement”) be accelerated to November 16, 2018 at 4:30 pm EST or as soon as practicable thereafter.
The cooperation of the staff in meeting the Company’s request is very much appreciated. Please call Amy Trombly at (617) 243-0060 if you have any questions or if we can otherwise be of assistance to you.
Very truly yours,
Sonoma Pharmaceuticals, Inc. /s/ Jim Schutz By: Jim Schutz Chief Executive Officer |
cc: Amy Trombly, Esq.
